FIELD: medicine.
SUBSTANCE: invention provides using a prepared compound of a ghrelin splicing version for preparing an effective drug preparation activating body weight and food intake gain and/or stimulating growth hormone release, as well as for treating or preventing cachexia, lipodystrophy and muscle atrophy.
EFFECT: higher clinical effectiveness.
6 cl, 6 dwg, 13 ex
| Title | Year | Author | Number |
|---|---|---|---|
| COMPOSITIONS, AGENTS, KITS AND TECHNIQUES FOR DIAGNOSING, MONITORING AND TREATING OBESITY AND/OR DIABETES | 2004 |
|
RU2420583C2 |
| THERAPEUTIC OR PROPHYLACTIC AGENT FOR TREATING OR PREVENTING CACHEXIA | 2020 |
|
RU2825649C1 |
| ANALOGUES OF GHRELIN SUBSTITUTED AT N-END | 2007 |
|
RU2459831C2 |
| THERAPEUTIC AGENT FOR AMYOTROPHIC LATERAL SCLEROSIS | 2013 |
|
RU2655811C2 |
| PEPTIDE COMPOSITIONS | 2014 |
|
RU2725150C2 |
| THERAPEUTIC MEDICATION FOR ACCELERATED SKIN HEALING, WHICH CONTAINS AS ACTIVE INGREDIENT GRELIN AND ITS DERIVATIVES OR SUBSTANCE INFLUENCING GHS-RLa RECEPTOR | 2006 |
|
RU2420306C2 |
| PEPTIDE HAVING AMYLIN PROPERTIES (VERSIONS) AND USE THEREOF (VERSIONS) | 2005 |
|
RU2385878C2 |
| PHARMACEUTICAL COMPOSITIONS | 2014 |
|
RU2690377C2 |
| HYDANTOIN MODIFIED MELANOCORTIN RECEPTOR LIGANDS | 2008 |
|
RU2450017C2 |
| STIMULATOR OF PANCREATIC BETA-CELL REGENERATION AND INSULIN PRODUCTION IN PANCREATIC BETA-CELLS | 2006 |
|
RU2403058C2 |
